A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Safety and efficacy of Efruxifermin in subjects with Non-Cirrhotic Non-alcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date1/02/242/02/26

Keywords

  • clinical trial
  • Efruxifermin
  • Non-alcoholic Steatohepatitis
  • Non-Cirrhotic
  • Fibrosis